A predictive scale for evaluating cyclin-dependent kinase substrates - A comparison of p34(cdc2) and p33(cdk2)

被引:133
|
作者
Holmes, JK [1 ]
Solomon, MJ [1 ]
机构
[1] YALE UNIV, SCH MED, DEPT MOL BIOPHYS & BIOCHEM, NEW HAVEN, CT 06520 USA
关键词
D O I
10.1074/jbc.271.41.25240
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein phosphorylation by members of the Cdk (cyclin dependent kinase) family of protein kinases is necessary for progression through the cell cycle. However, the primary sequence determinants of Cdk substrate specificity have get to be examined quantitatively. We have used a panel of glutathione S-transferase peptide fusions to investigate the fine-structure specificity of p33(cdk2) and p34(cdc2). Our data indicate that the generally held consensus sequences for p34(cdc2) represent a significant oversimplification of its true specificity and that this specificity is conserved between species. p33(cdk2) and p34(cdc2) have similar but distinct substrate specificities that are affected modestly by the associated cyclin subunit, We derive specific values of phosphorylation efficiencies by these enzymes that can be used to estimate the phosphorylation potential of proposed Cdk substrates.
引用
收藏
页码:25240 / 25246
页数:7
相关论文
共 50 条
  • [21] Kinetic characterisation of p34(cdc2)/cyclin B kinase by the scintillation proximity assay (SPA).
    SpencerFry, J
    Brophy, G
    OBeirne, G
    Cook, ND
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 2111 - 2111
  • [22] RELEASE FROM G(0)/G(1) ARREST INDUCED BY DIMETHYL-SULFOXIDE IN HUMAN LYMPHOID-CELLS - REGULATION OF SYNTHESIS AND ACTIVATION OF THE P33(CDK2) AND P34(CDC2) KINASES
    TAKASE, K
    TERADA, N
    SZEPESI, A
    TERAOKA, H
    GELFAND, EW
    LUCAS, JJ
    CELL GROWTH & DIFFERENTIATION, 1994, 5 (10): : 1051 - 1059
  • [23] INVOLVEMENT OF P34(CDC2) KINASE DURING PALATE MORPHOGENESIS IN QUAIL
    HEHN, BM
    YOUNG, AV
    SANGHERA, JS
    PELECH, SL
    SHAH, RM
    JOURNAL OF DENTAL RESEARCH, 1995, 74 : 64 - 64
  • [24] DIRECT PHOSPHORYLATION OF P34(CDC2) BY PROTEIN-KINASE-C
    JOHNSON, MR
    PALAZZO, RE
    ECKBERG, WR
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A342 - A342
  • [25] Overexpression of p34(cdc2) protein kinase in epithelial ovarian carcinoma
    Barrette, BA
    Srivatsa, PJ
    Cliby, WA
    Keeney, GL
    Suman, VJ
    Podratz, KC
    Roche, PC
    MAYO CLINIC PROCEEDINGS, 1997, 72 (10) : 925 - 929
  • [26] THE IDENTIFICATION OF A CAENORHABDITIS-ELEGANS HOMOLOG OF P34(CDC2) KINASE
    MORI, H
    PALMER, RE
    STERNBERG, PW
    MOLECULAR & GENERAL GENETICS, 1994, 245 (06): : 781 - 786
  • [27] Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2
    Morisaki, H
    Fujimoto, A
    Ando, A
    Nagata, Y
    Ikeda, K
    Nakanishi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (02) : 386 - 390
  • [28] REQUIREMENT FOR P34(CDC2) KINASE IS RESTRICTED TO MITOSIS IN THE MAMMALIAN CDC2 MUTANT FT210
    HAMAGUCHI, JR
    TOBEY, RA
    PINES, J
    CRISSMAN, HA
    HUNTER, T
    BRADBURY, EM
    JOURNAL OF CELL BIOLOGY, 1992, 117 (05): : 1041 - 1053
  • [29] The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis
    Hakem, A
    Sasaki, T
    Kozieradzki, I
    Penninger, JM
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06): : 957 - 967
  • [30] Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5
    Meijer, L.
    Borgne, A.
    Mulner, O.
    Chong, J. P. J.
    European Journal of Biochemistry, 243 (1-2):